CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients
Open Access
- 12 March 2015
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (12) , 10592-10603
Abstract
CD163+ tumor-associated macrophages (TAMs) play an important role in the progression of cancer. However, the significance of CD163+ TAMs in malignant pleural effusion (MPE) is still unclear. The aim of this study is to evaluate the prognostic value of CD163+ TAMs in MPE, and the regulatory effect of an immune adjuvant (pseudomonas aeruginosa - mannose-sensitive hemagglutinin, PA-MSHA, which is used for MPE treatment in clinic) on CD163+ TAMs in MPE. Here, we found that the percentage of CD163+ TAMs in MPE was significantly higher than that in non-malignant pleural effusion (P<0.001). More importantly, CD163+ TAMs in MPE patients were an independent prognostic factor for progression-free survival. M2-related cytokines were highly expressed in MPE-derived CD163+ TAMs than in MPE-derived CD163- macrophages (P<0.05). CD163+ TAMs frequency in MPE patients was obviously reduced after PA-MSHA treatment in clinic (P<0.05). After treatment with PA-MSHA, M2 macrophages were re-educated to M1 macrophages in vitro. TLR4 blocking antibody inhibited M2 macrophages polarization to M1 macrophages induced by PA-MSHA. These findings highlight that accumulation of CD163+ TAMs in MPE caused by lung cancer is closely correlated with poor prognosis. CD163+ TAMs are associated with therapeutic effect in MPE. PA-MSHA re-educates CD163+ TAMs to M1 macrophages through TLR4-mediated pathway in MPE.Keywords
This publication has 38 references indexed in Scilit:
- The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal CancerPLOS ONE, 2012
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patientsBMC Cancer, 2012
- Differential macrophage programming in the tumor microenvironmentTrends in Immunology, 2012
- Tumour macrophages as potential targets of bisphosphonatesJournal of Translational Medicine, 2011
- The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival timeBMC Cancer, 2010
- The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung CancerPLOS ONE, 2009
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis, 2009
- Trophic macrophages in development and diseaseNature Reviews Immunology, 2009
- Altered macrophage differentiation and immune dysfunction in tumor developmentJournal of Clinical Investigation, 2007
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004